Publicly Traded Cannabis Stock News

GrowGeneration Uplists to OTCQX

OTC Markets Group Welcomes GrowGeneration to OTCQX NEW YORK, Oct. 10, 2017 /PRNewswire/ — OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global...
- October 10th, 2017 at 9:06 am

Aurora Cannabis Raises $50.1mm at $3.00 Per Share

Aurora Cannabis Announces $50 Million Bought Deal Financing Post-Financing Cash Position in Excess of $175 Million Fueling Continued Aggressive Global Expansion VANCOUVER, Oct. 10, 2017 /CNW/ – Aurora Cannabis...
- October 10th, 2017 at 8:01 am

Big Banks Warm Up to Canadian Cannabis Industry

While cannabis is federally legal in Canada for medicinal purposes, several of the largest banks have avoided the sector, allowing Alterna Savings to become one of the early leaders...
- October 5th, 2017 at 11:47 am

iAnthus to Host Company Presentation at New West Summit

NEW YORK, NY and TORONTO, ON — (Marketwired) — 10/05/17 — iAnthus Capital Holdings, Inc. (“iAnthus” or “the Company”), (CSE: IAN)(CSE: IAN.CN)(CNSX: IAN)(OTCQB: ITHUF), which owns, operates, and partners...
- October 5th, 2017 at 7:39 am

Maricann Names New CFO with Pharmaceutical Experience

Maricann Announces Appointment of New Chief Financial Officer TORONTO, ONTARIO–(Marketwired – Oct. 3, 2017) – Maricann Group Inc. (CSE: MARI)(CSE: MARI.CN) (CNSX: MARI) (OTCQB: MRRCF) (FRANKFURT: 75M) (“Maricann” or...
- October 3rd, 2017 at 5:31 pm

Emblem to Develop Oral Sustained Release Product for Cannabinoids

Emblem Announces Exclusive Agreement with Canntab Therapeutics for Cannabinoid Based Oral Sustained Release Formulation PARIS, Ontario, Oct. 03, 2017 (GLOBE NEWSWIRE) — Emblem Corp. (TSXV:EMC) (EMC.WT) (OTC: EMMBF) (“Emblem”...
- October 3rd, 2017 at 5:12 pm

Emerald Health Names New CEO

Emerald Health Therapeutics Appoints Pharmaceutical Marketing and Biotech Executive Chris Wagner as CEO VICTORIA, British Columbia, Oct. 02, 2017 (GLOBE NEWSWIRE) — Emerald Health Therapeutics Inc. (“EHT”) (TSXV: EMH)...
- October 2nd, 2017 at 7:33 am

BCC Reports $5.1 Million Revenue in Q1

BCC Reports Q1 Fiscal 2018 Results TORONTO, Sept. 28, 2017 (GLOBE NEWSWIRE) — The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) reported its financial results for the...
- September 28th, 2017 at 10:22 pm